CD274 and neoplasm: Therefore, the combination of ferroptosis-targeting compounds has demonstrated significant efficacy; specifically, the integration of ferroptosis agonists with PD-1/PD-L1 inhibitors enhances anti-tumor effects, and when combined with chemotherapy or radiotherapy, it synergistically eradicates tumor cells through diverse mechanisms [4].